Tag Archives: long-acting insulin

A patient arrives at the pharmacy expecting their usual insulin refill, only to discover the box, brand name, and pen device suddenly look different. The pharmacist explains that the medication is an interchangeable biosimilar approved for automatic substitution. Although the insulin is considered clinically equivalent, the unexpected switch can still …

The arrival of a once-weekly basal insulin option marks one of the most meaningful advances in insulin therapy in decades. For years, daily basal injections have been the standard of care for people with type 1 and type 2 diabetes. However, many patients struggle with adherence, missed doses, and therapeutic …

Imagine reducing your patients’ insulin injections from 365 a year to just 52. That’s the promise of once‑weekly insulin — a next-generation option designed to simplify treatment, enhance adherence, and improve patient outcomes. While this innovation is gaining traction, many healthcare providers still have questions about when and how to …